Key result
Hypertension is linked to a more than threefold higher prevalence of metabolic syndrome.
Why the study?
Hypertension is a major risk factor for cardiovascular disease and a key feature of metabolic syndrome, but comparisons of metabolic syndrome features and prevalence between hypertensive and non-hypertensive adults needed evaluation.
Does hypertension increase the prevalence of metabolic syndrome in adults aged 35-55 years?
Cross-Sectional (n=120)
No
Does hypertension increase the prevalence of metabolic syndrome in adults aged 35-55 years?
Hypertensive individuals have a significantly higher prevalence of metabolic syndrome, highlighting the need for early screening and preventive strategies in this population.
Answers are grounded in this paper and cite their sources.
Hypertension was associated with higher metabolic syndrome prevalence in adults 35-55; leaves open causal links and whether screening alters outcomes.
Background and aims Hypertension is a major risk factor of cardiovascular diseases (CVDs), which attributes to one‐third of all deaths worldwide. It is also considered as a key feature of metabolic syndrome (MetS). The aim of the present study was to compare the presence of characteristic features of MetS in hypertensive and non‐hypertensive males and females and find out the percentages of MetS in hypertensive and non‐hypertensive adults. Methods This was a cross‐sectional study, involving 120 participants that included 60 hypertensives and 60 non‐hypertensives (35‐55 years). Data were obtained through an interviewer‐administered questionnaire. Fasting blood sugar (FBS) and lipid parameters [triglyceride‐(TG), high density lipoprotein (HDL)] were analyzed, and waist circumference (WC) was measured. Percentages of MetS among hypertensive and non‐hypertensive groups were determined according to both modified Adult Treatment Panel III (ATP III) and new International Diabetes Federation (IDF) criteria. Results were analyzed using SPSS version 21. Results Among the characteristic features of MetS, mean FBS and WC were significantly higher in hypertensive males compared with non‐hypertensive males ( P < .001 and P = .002 respectively), while mean value of TG was significantly higher ( P = .005) in hypertensive females compared with non‐hypertensive females. Further, the percentage of subjects in the total hypertensive group with increased FBS and increased WC was significantly higher than the non‐ hypertensive group. The percentage of subjects with MetS was significantly ( P < .001) higher in hypertensive group (68%) compared with non‐hypertensive group (20%) according to modified ATP III criteria. When compared with new IDF criteria, it was 63% and 20%, respectively. Conclusion The percentage of subjects with increased FBS, WC, and MetS was significantly higher in the hypertensive group compared with non‐hypertensives group. These findings emphasize the urgent need to develop national strategies for early detection, and to take preventive measures to make people aware of the impact of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Senarathne et al. (2021) conducted a cross-sectional in Hypertension (n=120). Hypertension vs. Non-hypertensive was evaluated on Presence of Metabolic Syndrome (modified ATP III criteria) (p=<0.001). Hypertension was associated with a significantly higher prevalence of metabolic syndrome compared to non-hypertensive controls (68% vs 20%, p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: